Table 4.
Study group | ||||||
---|---|---|---|---|---|---|
Group A (n = 78) | Group B (n = 26) | All (n = 104) | p-value | |||
Additional agent used | Aztreonam Meropenem Fosfomycin Tigecycline Meropenem + tigecycline Minocycline |
n (%) | 48 (61.5) 0 (0) 0 (0) 0 (0) 0 (0) 0 |
0 9 (34.6) 7 (26.9) 2 (7.7) 3 (11.5) 5 (19.2) |
48 (46.1) 9 (8.6) 7 (6.7) 2 (1.9) 3 (2.9) 5 (4.8) |
|
Additional treatment duration (days) | Median (range)§ | 8 (4–14) | 8 (5–15) | 8 (4–15) | 0.908NS |
§p-value by Mann–Whitney U test; the rest of the p-values by Chi-square test or Fisher's exact probability test. p-value < 0.05 is considered to be statistically significant. NS, statistically non-significant